Board of Directors
Scientific Advisory Committee


Suresh B. Borsadia - President & CEO, Director, Founder

Suresh has more than fourteen years experience in the pharmaceutical and drug delivery industry, with expertise and experience in R&D, business and corporate development activities. Suresh has a demonstrated record of successfully managing multiple projects and building R&D organizations in early stage companies. Prior to founding Abeille Pharmaceuticals, he was with Lavipharm for seven years, where he played a leading role in the company's R&D, in-licensing, and out-licensing activities. While at Lavipharm, he was part of the Senior Management team involved in M&A and fund raising activities. Prior to Lavipharm he worked at TheraTech, Inc., (now Watson Pharmaceuticals) and Bertek Inc., (now Mylan Technologies, a Division of Mylan Labs.).


Kalpana Patel, Ph.D. - VP, Strategic Planning & Alliance Management, Director

Kalpana has more than twelve years of experience in the pharmaceutical industry. She has led pre-formulation, formulation, process development and validation initiatives for a broad range RX, RX to OTC switches, OTC products and medical devices. Kalpana most recently was the Pipeline Development Director for Johnson & Johnson Consumer Companies. During her tenure at J&J, she held leadership responsibilities involving product development, life-cycle management, and was involved in advisory meetings with thought leaders. In addition, she was actively involved in interaction with global regulatory bodies. While at J&J, she also founded the Johnson & Johnson community of product/process development.


Jane M. Maida - VP, Chief Financial Officer (CFO)

Jane brings more than fifteen years of healthcare industry financial experience to Abeille. Most recently, she served as CFO and Chief Accounting Officer of Physiome Sciences, a biotechnology company focusing on the software development for modeling of various cells, tissues and organs. Prior to that, she was Vice President of Finance and Chief Accounting Officer of Cytogen Corporation (Nasdaq: CYTO), an oncology focused biotechnology company. Other positions include Chief Financial and Information Officer at Mustard Seed, a behavioral healthcare company and Director of Finance at The Liposome Company (now part of Elan), a biotechnology company.






© Abeille Pharmaceuticals, Inc 2004 - 2012